Bio-Thera Solutions, Ltd. — Investor Relations & Filings
About Bio-Thera Solutions, Ltd.
Bio-Thera Solutions, Ltd. is a biopharmaceutical company dedicated to the research and development of innovative therapeutics and high-quality biosimilars. The company focuses on addressing serious medical conditions across oncology, autoimmune, and cardiovascular therapeutic areas. Its portfolio includes several approved biosimilars, such as QLETLI (adalimumab), POBEVCY (bevacizumab), and TOFIDENCE (tocilizumab), alongside a robust pipeline of novel drug candidates, including antibody-drug conjugates (ADCs) and monoclonal antibodies. Bio-Thera utilizes advanced technology platforms to streamline the drug discovery and development process, aiming to expand global access to essential biologic medicines. The organization maintains a commitment to rigorous clinical standards and international regulatory compliance to deliver effective treatment options for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 百奥泰2025年度独立董事述职报告（HENRYWEI魏亨利） | 2026-04-27 | Chinese | |
| 百奥泰 关于全资子公司申请贷款业务及公司为其提供担保的公告 | 2026-04-27 | Chinese | |
| 百奥泰2025年度内部控制审计报告 | 2026-04-27 | Chinese | |
| 百奥泰2025年度审计报告及财务报表 | 2026-04-27 | Chinese | |
| 百奥泰2025年度募集资金存放、管理与实际使用情况专项报告的鉴证报告 | 2026-04-27 | Chinese | |
| 百奥泰2025年度独立董事述职报告（廖健） | 2026-04-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39231297 | 百奥泰2025年度独立董事述职报告（HENRYWEI魏亨利） | 2026-04-27 | Chinese | ||
| 39231292 | 百奥泰 关于全资子公司申请贷款业务及公司为其提供担保的公告 | 2026-04-27 | Chinese | ||
| 39231284 | 百奥泰2025年度内部控制审计报告 | 2026-04-27 | Chinese | ||
| 39231257 | 百奥泰2025年度审计报告及财务报表 | 2026-04-27 | Chinese | ||
| 39231136 | 百奥泰2025年度募集资金存放、管理与实际使用情况专项报告的鉴证报告 | 2026-04-27 | Chinese | ||
| 39231073 | 百奥泰2025年度独立董事述职报告（廖健） | 2026-04-27 | Chinese | ||
| 39231067 | 百奥泰2025年度内部控制评价报告 | 2026-04-27 | Chinese | ||
| 39231063 | 中国国际金融股份有限公司关于百奥泰生物制药股份有限公司2025年度募集资金存放、管理与实际使用情况的核查意见 | 2026-04-27 | Chinese | ||
| 39231057 | 百奥泰 关于向金融机构申请授信额度的公告 | 2026-04-27 | Chinese | ||
| 39231052 | 百奥泰 关于参加十五五·科创惠民——科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明会暨召开2026年第一季度业绩说明会的公告 | 2026-04-27 | Chinese | ||
| 39231047 | 百奥泰?关于2025年度利润分配预案的公告 | 2026-04-27 | Chinese | ||
| 39231042 | 百奥泰董事会关于独立董事独立性自查情况的专项意见 | 2026-04-27 | Chinese | ||
| 39231032 | 百奥泰2025年年度报告 | 2026-04-27 | Chinese | ||
| 39231029 | 百奥泰2025年度独立董事述职报告（陈旻湖） | 2026-04-27 | Chinese | ||
| 39231023 | 百奥泰 关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
Bio-Thera Solutions, Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58210/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58210 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58210 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58210 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58210}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bio-Thera Solutions, Ltd. (id: 58210)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.